Zacks.com on MSN5h
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
10x Genomics: Q4 Earnings Snapshot
PLEASANTON, Calif. AP) — 10x Genomics Inc. TXG) on Wednesday reported a loss of $49 million in its fourth quarter.